Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00686348 · ClinicalTrials.gov registry record
Somatuline® Depot (Lanreotide) for Acromegaly Post-Marketing Observational Study
A clinical trial, sponsored by Ipsen.
- Completed
- Registry status
- 260
- Enrollment target
NCT00686348 is a clinical trial that has completed, run by Ipsen. The registered enrollment target is 260 participants.
The verdict
NCT00686348 has completed, sponsored by Ipsen.
- COMPLETED
- Registry status
- 260 participants
- Enrollment target
Study Summary
To assess the safety and effectiveness of Somatuline® Depot (lanreotide) Injection when administered by a health care professional (HCP), the patient, the patient's partner or parent/guardian as part of their routine acromegaly care.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2008-05 |
| Est. Completion | 2015-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00686348
The ClinicalTrials.gov registry entry for NCT00686348 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ipsen, which has 85 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00686348 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00686348 about?
NCT00686348 is a clinical study titled "Somatuline® Depot (Lanreotide) for Acromegaly Post-Marketing Observational Study". To assess the safety and effectiveness of Somatuline® Depot (lanreotide) Injection when administered by a health care professional (HCP), the patient, the patient's partner or parent/guardian as part of their routine acromegaly care.
What is the current status of trial NCT00686348?
This trial is currently completed. The enrollment target is 260 participants. The study started on 2008-05. Estimated completion is 2015-11.
Who is sponsoring clinical trial NCT00686348?
This trial is sponsored by Ipsen, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.